Wenjing Zhou, Karin Jirström, Christine Johansson, Rose-Marie Amini, Carl Blomqvist, Olorunsola Agbaje, Fredrik Wärnberg. BMC Cancer 2010
Times Cited: 31
Times Cited: 31
Times Cited
Times Co-cited
Similarity
Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
45
Identification of a basal-like subtype of breast ductal carcinoma in situ.
Chad A Livasy, Charles M Perou, Gamze Karaca, David W Cowan, Diane Maia, Susan Jackson, Chiu-Kit Tse, Sarah Nyante, Robert C Millikan. Hum Pathol 2007
Chad A Livasy, Charles M Perou, Gamze Karaca, David W Cowan, Diane Maia, Susan Jackson, Chiu-Kit Tse, Sarah Nyante, Robert C Millikan. Hum Pathol 2007
38
Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review.
Sara A Lari, Henry M Kuerer. J Cancer 2011
Sara A Lari, Henry M Kuerer. J Cancer 2011
38
Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.
S E Clark, J Warwick, R Carpenter, R L Bowen, S W Duffy, J L Jones. Br J Cancer 2011
S E Clark, J Warwick, R Carpenter, R L Bowen, S W Duffy, J L Jones. Br J Cancer 2011
25
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
25
HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.
E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, R Saskin, J Spayne, C Taylor, L Paszat. Br J Cancer 2012
E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, R Saskin, J Spayne, C Taylor, L Paszat. Br J Cancer 2012
25
HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer.
Robert E Roses, E Carter Paulson, Anupama Sharma, Jeanne E Schueller, Harvey Nisenbaum, Susan Weinstein, Kevin R Fox, Paul J Zhang, Brian J Czerniecki. Cancer Epidemiol Biomarkers Prev 2009
Robert E Roses, E Carter Paulson, Anupama Sharma, Jeanne E Schueller, Harvey Nisenbaum, Susan Weinstein, Kevin R Fox, Paul J Zhang, Brian J Czerniecki. Cancer Epidemiol Biomarkers Prev 2009
22
The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
E K Latta, S Tjan, R K Parkes, F P O'Malley. Mod Pathol 2002
E K Latta, S Tjan, R K Parkes, F P O'Malley. Mod Pathol 2002
22
Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.
Bradley B Bryan, Stuart J Schnitt, Laura C Collins. Mod Pathol 2006
Bradley B Bryan, Stuart J Schnitt, Laura C Collins. Mod Pathol 2006
22
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
Torsten O Nielsen, Forrest D Hsu, Kristin Jensen, Maggie Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez-Boussard, Chad Livasy, Dave Cowan, Lynn Dressler,[...]. Clin Cancer Res 2004
Torsten O Nielsen, Forrest D Hsu, Kristin Jensen, Maggie Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez-Boussard, Chad Livasy, Dave Cowan, Lynn Dressler,[...]. Clin Cancer Res 2004
22
Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
Aslaug Aamodt Muggerud, Michael Hallett, Hilde Johnsen, Kristine Kleivi, Wenjing Zhou, Simin Tahmasebpoor, Rose-Marie Amini, Johan Botling, Anne-Lise Børresen-Dale, Therese Sørlie,[...]. Mol Oncol 2010
Aslaug Aamodt Muggerud, Michael Hallett, Hilde Johnsen, Kristine Kleivi, Wenjing Zhou, Simin Tahmasebpoor, Rose-Marie Amini, Johan Botling, Anne-Lise Børresen-Dale, Therese Sørlie,[...]. Mol Oncol 2010
22
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
Nina Bijker, Philip Meijnen, Johannes L Peterse, Jan Bogaerts, Irène Van Hoorebeeck, Jean-Pierre Julien, Massimiliano Gennaro, Philippe Rouanet, Antoine Avril, Ian S Fentiman,[...]. J Clin Oncol 2006
Nina Bijker, Philip Meijnen, Johannes L Peterse, Jan Bogaerts, Irène Van Hoorebeeck, Jean-Pierre Julien, Massimiliano Gennaro, Philippe Rouanet, Antoine Avril, Ian S Fentiman,[...]. J Clin Oncol 2006
22
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
22
Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast.
E Provenzano, J L Hopper, G G Giles, G Marr, D J Venter, J E Armes. Eur J Cancer 2003
E Provenzano, J L Hopper, G G Giles, G Marr, D J Venter, J E Armes. Eur J Cancer 2003
19
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
19
Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
19
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
D Craig Allred, Yun Wu, Sufeng Mao, Iris D Nagtegaal, Sangjun Lee, Charles M Perou, Syed K Mohsin, Peter O'Connell, Anna Tsimelzon, Dan Medina. Clin Cancer Res 2008
D Craig Allred, Yun Wu, Sufeng Mao, Iris D Nagtegaal, Sangjun Lee, Charles M Perou, Syed K Mohsin, Peter O'Connell, Anna Tsimelzon, Dan Medina. Clin Cancer Res 2008
19
Classification of ductal carcinoma in situ by gene expression profiling.
Juliane Hannemann, Arno Velds, Johannes B G Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver. Breast Cancer Res 2006
Juliane Hannemann, Arno Velds, Johannes B G Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver. Breast Cancer Res 2006
19
Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
Anne Vincent-Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, Rémi Goudefroye, Fabien Reyal, François Radvanyi, Rémy Salmon, Jean-Paul Thiery,[...]. Clin Cancer Res 2008
Anne Vincent-Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, Rémi Goudefroye, Fabien Reyal, François Radvanyi, Rémy Salmon, Jean-Paul Thiery,[...]. Clin Cancer Res 2008
19
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
19
Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics.
A Ringberg, L Anagnostaki, H Anderson, I Idvall, M Fernö. Eur J Cancer 2001
A Ringberg, L Anagnostaki, H Anderson, I Idvall, M Fernö. Eur J Cancer 2001
16
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
16
Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors.
Mona L Gauthier, Hal K Berman, Caroline Miller, Krystyna Kozakeiwicz, Karen Chew, Dan Moore, Joseph Rabban, Yunn Yi Chen, Karla Kerlikowske, Thea D Tlsty. Cancer Cell 2007
Mona L Gauthier, Hal K Berman, Caroline Miller, Krystyna Kozakeiwicz, Karen Chew, Dan Moore, Joseph Rabban, Yunn Yi Chen, Karla Kerlikowske, Thea D Tlsty. Cancer Cell 2007
16
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.
Rulla M Tamimi, Heather J Baer, Jonathan Marotti, Mark Galan, Laurie Galaburda, Yineng Fu, Anne C Deitz, James L Connolly, Stuart J Schnitt, Graham A Colditz,[...]. Breast Cancer Res 2008
Rulla M Tamimi, Heather J Baer, Jonathan Marotti, Mark Galan, Laurie Galaburda, Yineng Fu, Anne C Deitz, James L Connolly, Stuart J Schnitt, Graham A Colditz,[...]. Breast Cancer Res 2008
16
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
16
Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
16
Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence.
K Han, S Nofech-Mozes, S Narod, W Hanna, D Vesprini, R Saskin, C Taylor, I Kong, L Paszat, E Rakovitch. Clin Oncol (R Coll Radiol) 2012
K Han, S Nofech-Mozes, S Narod, W Hanna, D Vesprini, R Saskin, C Taylor, I Kong, L Paszat, E Rakovitch. Clin Oncol (R Coll Radiol) 2012
16
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
A Goldhirsch, W C Wood, A S Coates, R D Gelber, B Thürlimann, H-J Senn. Ann Oncol 2011
A Goldhirsch, W C Wood, A S Coates, R D Gelber, B Thürlimann, H-J Senn. Ann Oncol 2011
16
Quality aspects of the tissue microarray technique in a population-based cohort with ductal carcinoma in situ of the breast.
F Wärnberg, R-M Amini, M Goldman, K Jirström. Histopathology 2008
F Wärnberg, R-M Amini, M Goldman, K Jirström. Histopathology 2008
41
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial.
A Ringberg, H Nordgren, S Thorstensson, I Idvall, H Garmo, B Granstrand, L G Arnesson, K Sandelin, A Wallgren, H Anderson,[...]. Eur J Cancer 2007
A Ringberg, H Nordgren, S Thorstensson, I Idvall, H Garmo, B Granstrand, L G Arnesson, K Sandelin, A Wallgren, H Anderson,[...]. Eur J Cancer 2007
16
Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study.
Wenjing Zhou, Karin Jirström, Rose-Marie Amini, Marie-Louise Fjällskog, Thomas Sollie, Henrik Lindman, Therese Sørlie, Carl Blomqvist, Fredrik Wärnberg. BMC Cancer 2013
Wenjing Zhou, Karin Jirström, Rose-Marie Amini, Marie-Louise Fjällskog, Thomas Sollie, Henrik Lindman, Therese Sørlie, Carl Blomqvist, Fredrik Wärnberg. BMC Cancer 2013
16
Molecular phenotypes of DCIS predict overall and invasive recurrence.
K E Williams, N L P Barnes, A Cramer, R Johnson, K Cheema, J Morris, M Howe, N J Bundred. Ann Oncol 2015
K E Williams, N L P Barnes, A Cramer, R Johnson, K Cheema, J Morris, M Howe, N J Bundred. Ann Oncol 2015
16
Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
F Wärnberg, H Nordgren, L Bergkvist, L Holmberg. Br J Cancer 2001
F Wärnberg, H Nordgren, L Bergkvist, L Holmberg. Br J Cancer 2001
12
National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.
Carmen J Allegra, Denise R Aberle, Pamela Ganschow, Stephen M Hahn, Clara N Lee, Sandra Millon-Underwood, Malcolm C Pike, Susan D Reed, Audrey F Saftlas, Susan A Scarvalone,[...]. J Natl Cancer Inst 2010
Carmen J Allegra, Denise R Aberle, Pamela Ganschow, Stephen M Hahn, Clara N Lee, Sandra Millon-Underwood, Malcolm C Pike, Susan D Reed, Audrey F Saftlas, Susan A Scarvalone,[...]. J Natl Cancer Inst 2010
12
Prognostic significance of HER-2/neu expression in patients with ductal carcinoma in situ.
Rodica Stackievicz, Haim Paran, Joelle Bernheim, Mayra Shapira, Neomy Weisenberg, Tzvi Kaufman, Ehud Klein, Mordechai Gutman. Isr Med Assoc J 2010
Rodica Stackievicz, Haim Paran, Joelle Bernheim, Mayra Shapira, Neomy Weisenberg, Tzvi Kaufman, Ehud Klein, Mordechai Gutman. Isr Med Assoc J 2010
40
High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS.
S Roka, M Rudas, S Taucher, P Dubsky, T Bachleitner-Hofmann, D Kandioler, M Gnant, R Jakesz. Eur J Surg Oncol 2004
S Roka, M Rudas, S Taucher, P Dubsky, T Bachleitner-Hofmann, D Kandioler, M Gnant, R Jakesz. Eur J Surg Oncol 2004
12
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
Maggie C U Cheang, David Voduc, Chris Bajdik, Samuel Leung, Steven McKinney, Stephen K Chia, Charles M Perou, Torsten O Nielsen. Clin Cancer Res 2008
Maggie C U Cheang, David Voduc, Chris Bajdik, Samuel Leung, Steven McKinney, Stephen K Chia, Charles M Perou, Torsten O Nielsen. Clin Cancer Res 2008
12
Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.
David J Dabbs, Mamatha Chivukula, Gloria Carter, Rohit Bhargava. Mod Pathol 2006
David J Dabbs, Mamatha Chivukula, Gloria Carter, Rohit Bhargava. Mod Pathol 2006
12
Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
D C Allred, J M Harvey, M Berardo, G M Clark. Mod Pathol 1998
D C Allred, J M Harvey, M Berardo, G M Clark. Mod Pathol 1998
12
Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes.
H Buerger, F Otterbach, R Simon, K L Schäfer, C Poremba, R Diallo, C Brinkschmidt, B Dockhorn-Dworniczak, W Boecker. J Pathol 1999
H Buerger, F Otterbach, R Simon, K L Schäfer, C Poremba, R Diallo, C Brinkschmidt, B Dockhorn-Dworniczak, W Boecker. J Pathol 1999
12
Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers.
Aye Aye Thike, Jabed Iqbal, Poh Yian Cheok, Angela Phek Yoon Chong, Gary Man-Kit Tse, Benita Tan, Patrick Tan, Nan Soon Wong, Puay Hoon Tan. Am J Surg Pathol 2010
Aye Aye Thike, Jabed Iqbal, Poh Yian Cheok, Angela Phek Yoon Chong, Gary Man-Kit Tse, Benita Tan, Patrick Tan, Nan Soon Wong, Puay Hoon Tan. Am J Surg Pathol 2010
12
12
Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
Karla Kerlikowske, Annette Molinaro, Imok Cha, Britt-Marie Ljung, Virginia L Ernster, Kim Stewart, Karen Chew, Dan H Moore, Fred Waldman. J Natl Cancer Inst 2003
Karla Kerlikowske, Annette Molinaro, Imok Cha, Britt-Marie Ljung, Virginia L Ernster, Kim Stewart, Karen Chew, Dan H Moore, Fred Waldman. J Natl Cancer Inst 2003
12
Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
12
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
D Craig Allred, Stewart J Anderson, Soonmyung Paik, D Lawrence Wickerham, Iris D Nagtegaal, Sandra M Swain, Elefetherios P Mamounas, Thomas B Julian, Charles E Geyer, Joseph P Costantino,[...]. J Clin Oncol 2012
D Craig Allred, Stewart J Anderson, Soonmyung Paik, D Lawrence Wickerham, Iris D Nagtegaal, Sandra M Swain, Elefetherios P Mamounas, Thomas B Julian, Charles E Geyer, Joseph P Costantino,[...]. J Clin Oncol 2012
12
Detection of ductal carcinoma in situ in women undergoing screening mammography.
Virginia L Ernster, Rachel Ballard-Barbash, William E Barlow, Yingye Zheng, Donald L Weaver, Gary Cutter, Bonnie C Yankaskas, Robert Rosenberg, Patricia A Carney, Karla Kerlikowske,[...]. J Natl Cancer Inst 2002
Virginia L Ernster, Rachel Ballard-Barbash, William E Barlow, Yingye Zheng, Donald L Weaver, Gary Cutter, Bonnie C Yankaskas, Robert Rosenberg, Patricia A Carney, Karla Kerlikowske,[...]. J Natl Cancer Inst 2002
12
Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
12
HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component.
Ning Liao, Guo-chun Zhang, Yan-hui Liu, Xue-rui Li, Meng Yao, Fang-ping Xu, Li Li, Yi-long Wu. Pathol Res Pract 2011
Ning Liao, Guo-chun Zhang, Yan-hui Liu, Xue-rui Li, Meng Yao, Fang-ping Xu, Li Li, Yi-long Wu. Pathol Res Pract 2011
12
Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
J P Julien, N Bijker, I S Fentiman, J L Peterse, V Delledonne, P Rouanet, A Avril, R Sylvester, F Mignolet, H Bartelink,[...]. Lancet 2000
J P Julien, N Bijker, I S Fentiman, J L Peterse, V Delledonne, P Rouanet, A Avril, R Sylvester, F Mignolet, H Bartelink,[...]. Lancet 2000
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.